XML 56 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Apr. 28, 2023
Apr. 29, 2022
Apr. 30, 2021
Income Statement [Abstract]      
Net sales $ 31,227 $ 31,686 $ 30,117
Costs and expenses:      
Cost of products sold, excluding amortization of intangible assets 10,719 10,145 10,483
Research and development expense 2,696 2,746 2,493
Selling, general, and administrative expense 10,415 10,292 10,148
Amortization of intangible assets 1,698 1,733 1,783
Restructuring charges, net 375 60 293
Certain litigation charges, net (30) 95 118
Other operating (income) expense, net (131) 862 315
Operating profit 5,485 5,752 4,484
Other non-operating income, net (515) (318) (336)
Interest expense, net 636 553 925
Income before income taxes 5,364 5,517 3,895
Income tax provision 1,580 456 265
Net income 3,784 5,062 3,630
Net income attributable to noncontrolling interests (26) (22) (24)
Net income attributable to Medtronic $ 3,758 $ 5,039 $ 3,606
Basic earnings per share (in dollars per share) $ 2.83 $ 3.75 $ 2.68
Diluted earnings per share (in dollars per share) $ 2.82 $ 3.73 $ 2.66
Basic weighted average shares outstanding (in shares) 1,329.8 1,342.4 1,344.9
Diluted weighted average shares outstanding (in shares) 1,332.8 1,351.4 1,354.0